LIGATION OF HLA CLASS-II MOLECULES PROMOTES SENSITIVITY TO CD95 (FAS ANTIGEN, APO-1)-MEDIATED APOPTOSIS

被引:35
作者
YOSHINO, T
CAO, L
NISHIUCHI, R
MATSUO, Y
YAMADORI, I
KONDO, E
TERAMOTO, N
HAYASHI, K
TAKAHASHI, K
KAMIKAWAJI, N
AKAGI, T
机构
[1] HAYASHIBARA BIOCHEM LABS INC,FUJISAKI CELL CTR,OKAYAMA,JAPAN
[2] KYUSHU UNIV,MED INST BIOREGULAT,FUKUOKA 812,JAPAN
关键词
HLA CLASS II; FAS ANTIGEN; APO-1; CD95; APOPTOSIS;
D O I
10.1002/eji.1830250811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD95 (Fas antigen/APO-1) is up-regulated in activated lymphocytes, and monoclonal antibody (mAb) to CD95 induces apoptosis. HLA class II molecules play a key role in antigen presentation, ligation of which induces signal transduction. We examined 18 lymphoid cell lines (15 B cell and 3 T cell lines) to investigate the effects of ligation of HLA class II molecules on CD95-mediated apoptosis. All of the five immature B cell lines were sensitive to anti-CD95 mAb, and ligation of HLA class II molecules promoted CD95-mediated apoptosis. In seven B-blastoid cell lines, two Burkitt lines were resistant to anti-CD95 mAb in spite of high expression of CD95. In three of five non-Burkitt B-blastoid lines, CD95-mediated apoptosis was augmented by treatment with anti-HLA class II mAb, while the other two lines lacking CD95 were resistant to anti-CD95 mAb. Three plasmacytic cell lines showed CD95-mediated apoptosis, but enhancement by anti-HLA class II mAb was slight in one cell line and was not observed in the other two lines. Out of three HLA class II antigen-positive T cell lines, CD95-mediated apoptosis was observed to some degree in one cell line but was not promoted by the treatment with anti-KLA class II mAb, and the other two cell lines were resistant to anti-CD95 mAb. Ligation of HLA class II molecules did not alter CD95 expression in the five cell lines examined, except Su-DHL-4 originated from a follicular lymphoma, which showed slight up-regulation. Taken together, ligation of HLA class II molecules apparently promotes CD95-mediated apoptosis in immature B cells and non-Burkitt a blasts. These findings highlight the role of HLA class LI molecules in CD95-mediated apoptosis, which may facilitate rapid clearance of functionally useless cells from the: immune system and might be involved in negative selection of B cells.
引用
收藏
页码:2190 / 2194
页数:5
相关论文
共 50 条
  • [21] FasL-Fas/APO-1(CD95)系统
    孙长凯
    鞠躬
    生理科学进展, 1997, (02) : 42 - 44
  • [22] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06) : 1675 - 1687
  • [23] FUNCTIONAL CONSEQUENCES OF APO-1/FAS (CD95) ANTIGEN EXPRESSION BY NORMAL AND NEOPLASTIC HEMATOPOIETIC-CELLS
    ROBERTSON, MJ
    MANLEY, TJ
    PICHERT, G
    CAMERON, C
    COCHRAN, KJ
    LEVINE, H
    RITZ, J
    LEUKEMIA & LYMPHOMA, 1995, 17 (1-2) : 51 - 61
  • [24] Inhibition of CD95 (Fas/Apo1)-mediated apoptosis by vaccinia virus WR
    Heinkelein, M
    Pilz, S
    Jassoy, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) : 8 - 14
  • [25] Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis
    Frei, K
    Ambar, B
    Adachi, N
    Yonekawa, Y
    Fontana, A
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) : 105 - 113
  • [26] Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development
    McLellan, AD
    Terbeck, G
    Mengling, T
    Starling, GC
    Kiener, PA
    Gold, R
    Bröcker, EB
    Leverkus, M
    Kämpgen, E
    CELL DEATH AND DIFFERENTIATION, 2000, 7 (10) : 933 - 938
  • [27] Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development
    A D McLellan
    G Terbeck
    T Mengling
    G C Starling
    P A Kiener
    R Gold
    E-B Bröcker
    M Leverkus
    E Kämpgen
    Cell Death & Differentiation, 2000, 7 : 933 - 938
  • [28] The expression and concentrations of Fas/APO-1 (CD95) antigen in patients with severe pre-eclampsia
    Darmochwal-Kolarz, D
    Leszczynska-Gorzelak, B
    Rolinski, J
    Oleszczuk, J
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 49 (02) : 153 - 164
  • [29] Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies
    Wang, DK
    Freeman, GJ
    Levine, H
    Ritz, J
    Robertson, MJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) : 409 - 417
  • [30] Expression of antigen CD95(Fas/APO-1) mediating apoptosis in hemoblastoses using monoclonal antibodies ICO-160.
    Polosukhina, ER
    Baryshnikov, AY
    Shishkin, YV
    Zabotina, TN
    Logacheva, NP
    Tupitsyn, NN
    Volkova, MA
    Turkina, AG
    Tsvetaeva, NV
    Golenkov, AK
    Shirin, AD
    Kataeva, EV
    Trifonova, EV
    Mitina, TA
    Mikhailova, IN
    Lysyuk, EY
    Mayakova, SA
    Kadagidze, ZG
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2000, 45 (04): : 3 - 6